Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Albumin-to-alkaline phosphatase ratio: A novel prognostic index for patients with driver mutation-negative advanced non-small cell lung cancer.

The clinical respiratory journal - 1 May 2021

Liu Xiaoqin, Li Yan, Zhao Qi, Jiang Hanyi, Ni Jun, Cai Hourong

Abstract excerpt

INTRODUCTION: Albumin-to-Alkaline Phosphatase Ratio (AAPR), a novel developed prognostic index for cancers. Chemotherapy was the only method for driver mutation-negative advanced non-small cell lung cancer (DANSCLC). OBJECTIVES: To evaluate the clinical significance of AAPR in these patients. METHODS: We retrospectively reviewed 167 DANSCLCs and 58 healthy controls. Associations of clinicopathological...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Albumins
Share to Alkaline Phosphatase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Non-Small-Cell Lung

Share to Lung Neoplasms

Share to Mutation

Share to Prognosis

Source

Identifiers

PMID: 33565707
DOI: 10.1111/crj.13339

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Albumin-to-alkaline phosphatase ratio: A novel prognostic index for patients with driver mutation-negative advanced non-small cell lung cancer.PMID 33565707Read ↗

Prognostic Nomogram to Predict the Overall Survival of Patients with “driver-gene-negative” Lung Adenocarcinoma (LUAD) and Its’ Biological Basis DecipheringSemantic proximity Read ↗

High fibrinogen-albumin ratio index predicts poor prognosis for lung adenocarcinoma patients undergoing epidermal growth factor receptor-tyrosine kinase inhibitor treatments.Semantic proximity Read ↗

The Prognostic and Predictive Value of Pretreatment Serum Tumor Markers in Lung Adenocarcinoma with Different EGFR StatusSemantic proximity Read ↗

Long noncoding RNA MALAT1 as a candidate serological biomarker for the diagnosis of non‐small cell lung cancer: A meta‐analysisSemantic proximity Read ↗

Serum albumin as a prognostic predictor reflecting host immunity in patients with non–small cell lung cancerSemantic proximity Read ↗

Biomarkers with predictive and prognostic function in non-small cell lung cancer: ready for prime time?Semantic proximity Read ↗

Prognostic importance of prognostic nutritional index and modified Glasgow prognostic score in advanced lung cancer with targetable mutation.Semantic proximity Read ↗

Utility of red cell distribution width as a diagnostic and prognostic marker in non-small cell lung cancerSemantic proximity Read ↗

Platelet/lymphocyte ratio is a significant prognostic factor for targeted therapy in patients with EGFR-mutated non-small-cell lung cancer.Semantic proximity Read ↗

Long intergenic noncoding RNA LINC00173 as a potential serum biomarker for diagnosis of non-small-cell lung cancerSemantic proximity Read ↗

Assessment of prognostic scores of brain metastases from lung adenocarcinoma with EGFR mutations.Semantic proximity Read ↗

Predictive value of direct bilirubin and total bile acid in lung adenocarcinoma patients treated with EGFR-TKIs.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.